Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: inappropriate route of administration; The patient had received the first Biontech vaccination on 04Apr2021. No previous illness, no long-term medication. On 08Apr2021 there was pulseless electrical activity with 1.5h resuscitation DD LAE; Dyspnoea; Backache; Thorax pain; This is a spontaneous report from a non-contactable consumer downloaded from the Agency Regulatory Authority-WEB, regulatory authority number DE-PEI-CADR2021046517. A 71-years-old male patient received bnt162b2 (COMIRNATY), dose 1 intravenous on 04Apr2021 (Batch/Lot Number: Unknown) as SIGNLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced the patient had received the first biontech vaccination on 04apr2021. no previous illness, no long-term medication. on 08apr2021 there was pulseless electrical activity with 1.5h resuscitation dd lae, dyspnoea on 07Apr2021, backache on 07Apr2021, thorax pain on 07Apr2021, inappropriate route of administration on an unspecified date. At the 07Apr2021 Back pain, chest pain, dyspnoea, no evidence of cardiac genesis at the family doctor.On 08Apr2021 PEA, 1.5h resuscitation without ROSC. If there is no CO2 via the endotracheal tube Especially LAE, start of lysis. The patient died on 08Apr2021. It was not reported if an autopsy was performed. Outcome of for Pulmonary embolism was fatal, of Back pain, chest pain and dyspnoea was not recovered. The seriousness criteria of Pulmonary embolism was death. No follow-up attempts are possible, information on batch number cannot be obtained.; Reported Cause(s) of Death: Lung embolism
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166